An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2

Andrew I Flyak1, Stormy E Ruiz1,2, Jordan Salas2

  • 1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States.

Elife
|March 4, 2020
PubMed